Logo image of DORM

DORMAN PRODUCTS INC (DORM) Stock Fundamental Analysis

NASDAQ:DORM - Nasdaq - US2582781009 - Common Stock - Currency: USD

111.18  -0.49 (-0.44%)

After market: 111.18 0 (0%)

Fundamental Rating

7

We assign a fundamental rating of 7 out of 10 to DORM. DORM was compared to 81 industry peers in the Automobile Components industry. Both the health and profitability get an excellent rating, making DORM a very profitable company, without any liquidiy or solvency issues. DORM has a correct valuation and a medium growth rate. This makes DORM very considerable for quality investing!


Dividend Valuation Growth Profitability Health

9

1. Profitability

1.1 Basic Checks

In the past year DORM was profitable.
DORM had a positive operating cash flow in the past year.
In the past 5 years DORM has always been profitable.
Each year in the past 5 years DORM had a positive operating cash flow.
DORM Yearly Net Income VS EBIT VS OCF VS FCFDORM Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M

1.2 Ratios

The Return On Assets of DORM (7.84%) is better than 91.36% of its industry peers.
Looking at the Return On Equity, with a value of 14.69%, DORM belongs to the top of the industry, outperforming 92.59% of the companies in the same industry.
With an excellent Return On Invested Capital value of 11.79%, DORM belongs to the best of the industry, outperforming 92.59% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for DORM is in line with the industry average of 8.88%.
The last Return On Invested Capital (11.79%) for DORM is above the 3 year average (9.34%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 7.84%
ROE 14.69%
ROIC 11.79%
ROA(3y)6.22%
ROA(5y)7.06%
ROE(3y)12.47%
ROE(5y)12.81%
ROIC(3y)9.34%
ROIC(5y)9.92%
DORM Yearly ROA, ROE, ROICDORM Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15 20

1.3 Margins

DORM's Profit Margin of 9.46% is amongst the best of the industry. DORM outperforms 96.30% of its industry peers.
DORM's Profit Margin has improved in the last couple of years.
DORM has a better Operating Margin (14.58%) than 98.77% of its industry peers.
DORM's Operating Margin has improved in the last couple of years.
DORM has a better Gross Margin (40.13%) than 95.06% of its industry peers.
DORM's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 14.58%
PM (TTM) 9.46%
GM 40.13%
OM growth 3Y4.55%
OM growth 5Y6.44%
PM growth 3Y-1.1%
PM growth 5Y2.27%
GM growth 3Y5.26%
GM growth 5Y3.2%
DORM Yearly Profit, Operating, Gross MarginsDORM Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30 40

8

2. Health

2.1 Basic Checks

DORM has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
The number of shares outstanding for DORM has been reduced compared to 1 year ago.
DORM has less shares outstanding than it did 5 years ago.
Compared to 1 year ago, DORM has an improved debt to assets ratio.
DORM Yearly Shares OutstandingDORM Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M
DORM Yearly Total Debt VS Total AssetsDORM Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B

2.2 Solvency

An Altman-Z score of 4.11 indicates that DORM is not in any danger for bankruptcy at the moment.
DORM's Altman-Z score of 4.11 is amongst the best of the industry. DORM outperforms 87.65% of its industry peers.
The Debt to FCF ratio of DORM is 2.51, which is a good value as it means it would take DORM, 2.51 years of fcf income to pay off all of its debts.
The Debt to FCF ratio of DORM (2.51) is better than 92.59% of its industry peers.
DORM has a Debt/Equity ratio of 0.35. This is a healthy value indicating a solid balance between debt and equity.
DORM's Debt to Equity ratio of 0.35 is on the low side compared to the rest of the industry. DORM is outperformed by 65.43% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.35
Debt/FCF 2.51
Altman-Z 4.11
ROIC/WACC1.31
WACC8.98%
DORM Yearly LT Debt VS Equity VS FCFDORM Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

2.3 Liquidity

DORM has a Current Ratio of 2.43. This indicates that DORM is financially healthy and has no problem in meeting its short term obligations.
Looking at the Current ratio, with a value of 2.43, DORM is in the better half of the industry, outperforming 79.01% of the companies in the same industry.
A Quick Ratio of 1.17 indicates that DORM should not have too much problems paying its short term obligations.
The Quick ratio of DORM (1.17) is better than 72.84% of its industry peers.
Industry RankSector Rank
Current Ratio 2.43
Quick Ratio 1.17
DORM Yearly Current Assets VS Current LiabilitesDORM Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

5

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 57.27% over the past year.
The Earnings Per Share has been growing by 21.83% on average over the past years. This is a very strong growth
Looking at the last year, DORM shows a small growth in Revenue. The Revenue has grown by 4.11% in the last year.
DORM shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 15.18% yearly.
EPS 1Y (TTM)57.27%
EPS 3Y15.37%
EPS 5Y21.83%
EPS Q2Q%40.13%
Revenue 1Y (TTM)4.11%
Revenue growth 3Y14.31%
Revenue growth 5Y15.18%
Sales Q2Q%7.99%

3.2 Future

The Earnings Per Share is expected to grow by 9.24% on average over the next years. This is quite good.
The Revenue is expected to grow by 4.83% on average over the next years.
EPS Next Y9.86%
EPS Next 2Y9.24%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year4.75%
Revenue Next 2Y4.83%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
DORM Yearly Revenue VS EstimatesDORM Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 500M 1B 1.5B 2B
DORM Yearly EPS VS EstimatesDORM Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2 4 6 8

4

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 15.57, the valuation of DORM can be described as correct.
DORM's Price/Earnings ratio is in line with the industry average.
DORM's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 28.29.
With a Price/Forward Earnings ratio of 14.17, DORM is valued correctly.
Compared to the rest of the industry, the Price/Forward Earnings ratio of DORM is on the same level as its industry peers.
Compared to an average S&P500 Price/Forward Earnings ratio of 21.32, DORM is valued a bit cheaper.
Industry RankSector Rank
PE 15.57
Fwd PE 14.17
DORM Price Earnings VS Forward Price EarningsDORM Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, DORM is valued a bit more expensive than 75.31% of the companies in the same industry.
The rest of the industry has a similar Price/Free Cash Flow ratio as DORM.
Industry RankSector Rank
P/FCF 17.73
EV/EBITDA 10.89
DORM Per share dataDORM EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 20 40 60

4.3 Compensation for Growth

The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
The excellent profitability rating of DORM may justify a higher PE ratio.
PEG (NY)1.58
PEG (5Y)0.71
EPS Next 2Y9.24%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for DORM!.
Industry RankSector Rank
Dividend Yield N/A

DORMAN PRODUCTS INC

NASDAQ:DORM (4/17/2025, 8:14:02 PM)

After market: 111.18 0 (0%)

111.18

-0.49 (-0.44%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupAutomobiles & Components
GICS IndustryAutomobile Components
Earnings (Last)02-26 2025-02-26/amc
Earnings (Next)05-05 2025-05-05/bmo
Inst Owners81.24%
Inst Owner Change0.32%
Ins Owners14.98%
Ins Owner Change-7.51%
Market Cap3.40B
Analysts82
Price Target141.01 (26.83%)
Short Float %2.22%
Short Ratio2.9
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)17.73%
Min EPS beat(2)9.67%
Max EPS beat(2)25.8%
EPS beat(4)4
Avg EPS beat(4)32.28%
Min EPS beat(4)9.67%
Max EPS beat(4)55.86%
EPS beat(8)5
Avg EPS beat(8)9.5%
EPS beat(12)6
Avg EPS beat(12)5.52%
EPS beat(16)7
Avg EPS beat(16)3.74%
Revenue beat(2)0
Avg Revenue beat(2)-1.73%
Min Revenue beat(2)-3.19%
Max Revenue beat(2)-0.28%
Revenue beat(4)0
Avg Revenue beat(4)-2.01%
Min Revenue beat(4)-3.19%
Max Revenue beat(4)-0.28%
Revenue beat(8)0
Avg Revenue beat(8)-2.96%
Revenue beat(12)3
Avg Revenue beat(12)-0.49%
Revenue beat(16)6
Avg Revenue beat(16)0.37%
PT rev (1m)0%
PT rev (3m)2.6%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-3.33%
EPS NY rev (1m)2.16%
EPS NY rev (3m)2.16%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0.42%
Revenue NY rev (1m)0%
Revenue NY rev (3m)1.23%
Valuation
Industry RankSector Rank
PE 15.57
Fwd PE 14.17
P/S 1.69
P/FCF 17.73
P/OCF 14.71
P/B 2.63
P/tB 5.94
EV/EBITDA 10.89
EPS(TTM)7.14
EY6.42%
EPS(NY)7.84
Fwd EY7.06%
FCF(TTM)6.27
FCFY5.64%
OCF(TTM)7.56
OCFY6.8%
SpS65.75
BVpS42.33
TBVpS18.73
PEG (NY)1.58
PEG (5Y)0.71
Profitability
Industry RankSector Rank
ROA 7.84%
ROE 14.69%
ROCE 15.74%
ROIC 11.79%
ROICexc 12.16%
ROICexgc 20.15%
OM 14.58%
PM (TTM) 9.46%
GM 40.13%
FCFM 9.54%
ROA(3y)6.22%
ROA(5y)7.06%
ROE(3y)12.47%
ROE(5y)12.81%
ROIC(3y)9.34%
ROIC(5y)9.92%
ROICexc(3y)9.58%
ROICexc(5y)10.64%
ROICexgc(3y)16.14%
ROICexgc(5y)16.08%
ROCE(3y)13.07%
ROCE(5y)14.22%
ROICexcg growth 3Y8.15%
ROICexcg growth 5Y10.63%
ROICexc growth 3Y3.74%
ROICexc growth 5Y2.76%
OM growth 3Y4.55%
OM growth 5Y6.44%
PM growth 3Y-1.1%
PM growth 5Y2.27%
GM growth 3Y5.26%
GM growth 5Y3.2%
F-Score8
Asset Turnover0.83
Health
Industry RankSector Rank
Debt/Equity 0.35
Debt/FCF 2.51
Debt/EBITDA 1.3
Cap/Depr 69.53%
Cap/Sales 1.96%
Interest Coverage 7.57
Cash Conversion 66.09%
Profit Quality 100.85%
Current Ratio 2.43
Quick Ratio 1.17
Altman-Z 4.11
F-Score8
WACC8.98%
ROIC/WACC1.31
Cap/Depr(3y)78.22%
Cap/Depr(5y)67.78%
Cap/Sales(3y)2.14%
Cap/Sales(5y)1.86%
Profit Quality(3y)77.16%
Profit Quality(5y)84.08%
High Growth Momentum
Growth
EPS 1Y (TTM)57.27%
EPS 3Y15.37%
EPS 5Y21.83%
EPS Q2Q%40.13%
EPS Next Y9.86%
EPS Next 2Y9.24%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)4.11%
Revenue growth 3Y14.31%
Revenue growth 5Y15.18%
Sales Q2Q%7.99%
Revenue Next Year4.75%
Revenue Next 2Y4.83%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y36.08%
EBIT growth 3Y19.51%
EBIT growth 5Y22.59%
EBIT Next Year29.58%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y16.29%
FCF growth 3Y33.52%
FCF growth 5Y23.87%
OCF growth 1Y10.68%
OCF growth 3Y32.07%
OCF growth 5Y19.38%